Fernández Fernández, A.; García Fortes, M.; Tormo Díaz, M.; Juan Marco, M.L.; Cuello García, R.; de La Fuente, A.; Serrano López, J.; Medina Pérez, M.Á.; Sánchez Chaparro, M.Á.; García Delgado, R.
Maintenance Treatment with 5-Azacitidine in Patients with Acute Myeloblastic Leukemia Ineligible for Intensive Treatment and with Response After Induction Chemotherapy: A Phase II Clinical Trial. Cancers 2025, 17, 2678.
https://doi.org/10.3390/cancers17162678
AMA Style
Fernández Fernández A, García Fortes M, Tormo Díaz M, Juan Marco ML, Cuello García R, de La Fuente A, Serrano López J, Medina Pérez MÁ, Sánchez Chaparro MÁ, García Delgado R.
Maintenance Treatment with 5-Azacitidine in Patients with Acute Myeloblastic Leukemia Ineligible for Intensive Treatment and with Response After Induction Chemotherapy: A Phase II Clinical Trial. Cancers. 2025; 17(16):2678.
https://doi.org/10.3390/cancers17162678
Chicago/Turabian Style
Fernández Fernández, Alfonso, María García Fortes, Mar Tormo Díaz, María Luz Juan Marco, Rebeca Cuello García, Adolfo de La Fuente, Josefina Serrano López, Mª Ángeles Medina Pérez, Miguel Ángel Sánchez Chaparro, and Regina García Delgado.
2025. "Maintenance Treatment with 5-Azacitidine in Patients with Acute Myeloblastic Leukemia Ineligible for Intensive Treatment and with Response After Induction Chemotherapy: A Phase II Clinical Trial" Cancers 17, no. 16: 2678.
https://doi.org/10.3390/cancers17162678
APA Style
Fernández Fernández, A., García Fortes, M., Tormo Díaz, M., Juan Marco, M. L., Cuello García, R., de La Fuente, A., Serrano López, J., Medina Pérez, M. Á., Sánchez Chaparro, M. Á., & García Delgado, R.
(2025). Maintenance Treatment with 5-Azacitidine in Patients with Acute Myeloblastic Leukemia Ineligible for Intensive Treatment and with Response After Induction Chemotherapy: A Phase II Clinical Trial. Cancers, 17(16), 2678.
https://doi.org/10.3390/cancers17162678
